NV
Northpond Ventures’s Candel Therapeutics CADL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $13.4M | Hold |
1,935,215
| – | – | 30.72% | 3 |
|
|
2024
Q2 | $12M | Hold |
1,935,215
| – | – | 21.71% | 3 |
|
|
2024
Q1 | $3.06M | Hold |
1,935,215
| – | – | 2.98% | 4 |
|
|
2023
Q4 | $2.84M | Hold |
1,935,215
| – | – | 13.54% | 3 |
|
|
2023
Q3 | $1.78M | Hold |
1,935,215
| – | – | 5.13% | 3 |
|
|
2023
Q2 | $2.44M | Hold |
1,935,215
| – | – | 4.05% | 4 |
|
|
2023
Q1 | $2.61M | Hold |
1,935,215
| – | – | 1.49% | 5 |
|
|
2022
Q4 | $3.46M | Hold |
1,935,215
| – | – | 1.88% | 5 |
|
|
2022
Q3 | $6.08M | Hold |
1,935,215
| – | – | 4.26% | 5 |
|
|
2022
Q2 | $6.27M | Hold |
1,935,215
| – | – | 5.97% | 5 |
|
|
2022
Q1 | $9.85M | Hold |
1,935,215
| – | – | 5.31% | 5 |
|
|
2021
Q4 | $15.1M | Buy |
+1,935,215
| New | +$15.1M | 5.3% | 4 |
|